Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection

被引:236
作者
Hislop, AD [1 ]
Annels, NE [1 ]
Gudgeon, NH [1 ]
Leese, AM [1 ]
Rickinson, AB [1 ]
机构
[1] Univ Birmingham, CRC Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
关键词
Epstein-Barr virus; CD8(+) T lymphocytes; infectious' mononucleosis; kinetics; phenotype;
D O I
10.1084/jem.20011692
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary virus infection often elicits a large CD8(+) T cell response which subsequently contracts to a smaller memory T cell pool; the relationship between these two virus-specific populations is not well understood. Here we follow the human CD8(+) T cell response to Epstein-Barr virus (EBV) from its primary phase in infectious mononucleosis (IM) through to the persistent carrier state. Using HLA-A2.1 or B8 tetramers specific for four lytic cycle and three latent cycle epitopes, we find marked differences in the epitope-specific composition of the T cell populations between the two phases of infection. The primary response is dominated by lytic epitope specificities which are severely culled (and in one case extinguished) with resolution of the acute infection; in contrast latent epitope specificities are less abundant, if present at all, in acute IM but often then increase their percentage representation in the CD8 pool. Even comparing epitopes of the same type, the relative size of responses seen in primary infection does not necessarily correlate with that seen in the longer term. We also follow the evolution of phenotypic change in these populations and show that, from a uniform CD45RA(-)RO(+)CCR7-phenotype in IM, lytic epitope responses show greater reversion to a CD45RA(-)PO(-) phenotype whereas latent epitope responses remain CD45RA(-)RO(+) with a greater tendency to acquire CCR7. Interestingly these phenotypic distinctions reflect the source of the epitope as lytic or latent, and not the extent to which the response has been amplified in vivo.
引用
收藏
页码:893 / 905
页数:13
相关论文
共 50 条
  • [21] Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro
    Gansuvd, B
    Hagihara, M
    Munkhbat, B
    Kanai, N
    Morita, N
    Munkhtuvshin, N
    Chargui, J
    Kato, S
    Hotta, T
    Tsuji, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (01) : 107 - 114
  • [22] Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma
    Fogg, Mark
    Murphy, John R.
    Lorch, Jochen
    Posner, Marshall
    Wang, Fred
    VIROLOGY, 2013, 441 (02) : 107 - 113
  • [23] Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8+ T cells during highly active antiretroviral therapy is associated with an increase in CD4+ T cells
    Kostense, S
    Otto, SA
    Knol, GJ
    Manting, EH
    Nanlohy, NM
    Jansen, C
    Lange, JMA
    van Oers, MHJ
    Miedema, F
    van Baarle, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (04) : 1080 - 1089
  • [24] CD8+ T-lymphocyte infiltration and apoptosis in fulminant Epstein-Barr virus hepatitis in a previously healthy girl
    Koga, M
    Yoshitomi, T
    Tanaka, K
    Inomata, Y
    Murakami, T
    Furukawa, S
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2000, 19 (06): : 449 - 454
  • [25] Virus-specific cytotoxic T cell responses are associated with immunity of the cottontop tamarin to Epstein-Barr virus (EBV)
    Wilson, AD
    Shooshstari, M
    Finerty, S
    Watkins, P
    Morgan, AJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (02) : 199 - 205
  • [26] CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients
    Lin, Xiaorong
    Gudgeon, Nancy H.
    Hui, Edwin P.
    Jia, Hui
    Qun, Xue
    Taylor, Graham S.
    Barnardo, Martin C. N. M.
    Lin, C. Kit
    Rickinson, Alan B.
    Chan, Anthony T. C.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (07) : 963 - 975
  • [27] CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1
    Lee, SP
    Brooks, JM
    Al-Jarrah, H
    Thomas, WA
    Haigh, RT
    Taylor, GS
    Humme, S
    Schepers, A
    Hammerschmidt, W
    Yates, JL
    Rickinson, AB
    Blake, NW
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) : 1409 - 1420
  • [28] Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones
    Honda, S
    Takasaki, T
    Okuno, K
    Yasutomi, M
    Kurane, I
    ACTA VIROLOGICA, 1998, 42 (05) : 307 - 313
  • [29] An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness
    Ouyang, Q
    Wagner, WM
    Walter, S
    Müller, CA
    Wikby, A
    Aubert, G
    Klatt, T
    Stevanovic, S
    Dodi, T
    Pawelec, G
    MECHANISMS OF AGEING AND DEVELOPMENT, 2003, 124 (04) : 477 - 485
  • [30] Lack of Epstein-Barr virus-and HIV specific CD27-CD8+T cells is associated with progression to viral disease in HIV infection
    van Baarle, D
    Kostense, S
    Hovenkamp, E
    Ogg, G
    Nanlohy, N
    Callan, MFC
    Dukers, NHTM
    McMichael, AJ
    van Oers, MHJ
    Miedema, F
    AIDS, 2002, 16 (15) : 2001 - 2011